Přejít k obsahu
Merck
Všechny fotografie(3)

Key Documents

View All Documentation

129550

Sigma-Aldrich

4-(2-Keto-1-benzimidazolinyl)piperidine

98%

Přihlásitk zobrazení cen stanovených pro organizaci a smluvních cen
Všechny fotografie(3)

About This Item

Empirický vzorec (Hillův zápis):
C12H15N3O
Číslo CAS:
20662-53-7
Molekulová hmotnost:
217.27
EC Number:
243-950-3
MDL number:
MFCD00005714
UNSPSC Code:
12352100
PubChem Substance ID:
24847910
NACRES:
NA.22

assay

98%

form

solid

mp

183-185 °C (lit.)

SMILES string

O=C1Nc2ccccc2N1C3CCNCC3

InChI

1S/C12H15N3O/c16-12-14-10-3-1-2-4-11(10)15(12)9-5-7-13-8-6-9/h1-4,9,13H,5-8H2,(H,14,16)

InChI key

BYNBAMHAURJNTR-UHFFFAOYSA-N

Application

4-(2-Keto-1-benzimidazolinyl)piperidine was used to study the structure–activity relationships with several potent and selective analogues.

pictograms

Skull and crossbones
GHS06

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

Osvědčení o analýze (COA)

Vyhledejte osvědčení Osvědčení o analýze (COA) zadáním čísla šarže/dávky těchto produktů. Čísla šarže a dávky lze nalézt na štítku produktu za slovy „Lot“ nebo „Batch“.

Již tento produkt vlastníte?

Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.

Navštívit knihovnu dokumentů

Mike Frohn et al.
Bioorganic & medicinal chemistry letters, 17(23), 6633-6637 (2007-10-09)
We report the development of the novel N-substituted benzimidazole 11 as a potent and selective human formyl peptide receptor-like 1 (hFPRL1) agonist. This compound and its less active enantiomer 12 were identified as useful tools for studying receptor function in
Eduard Badarau et al.
Bioorganic & medicinal chemistry letters, 19(6), 1600-1603 (2009-02-25)
A new group of serotoninergic 5-HT(1A) or 5-HT(7) receptor ligands was identified. These compounds were designed and synthesized on a benzimidazolone scaffold and they enrich the well-known arylpiperazine class of 5-HT ligands. Diverse pharmacomodulations induced a shift in the affinity
Ronald Palin et al.
Bioorganic & medicinal chemistry letters, 15(3), 589-593 (2005-01-25)
A series of 3-phenoxypropyl piperidine analogues have been discovered as novel ORL1 receptor agonists. Structure-activity relationships have been explored around the 3-phenoxypropyl region with several potent and selective analogues identified.
Anna-Maria Monforte et al.
Bioorganic & medicinal chemistry, 17(16), 5962-5967 (2009-07-21)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) have become very important components in the antiretroviral combination therapies used to treat HIV. Recently, our group identified some 1,3-dihydrobenzimidazol-2-one derivatives and their sulfones as a potent and novel class of NNRTIs. We herein report
Hirofumi Omura et al.
Bioorganic & medicinal chemistry letters, 18(11), 3310-3314 (2008-04-29)
Benzimidazolone derivatives were discovered as novel CB2 selective agonists. Structure Activity Relationship (SAR) studies around them were examined to improve metabolic stability. Compound 39 exhibited excellent metabolic stability in human liver microsomes (HLM) and significant attenuation of the chronic colonic
Zobrazit všechny související dokumenty

Náš tým vědeckých pracovníků má zkušenosti ve všech oblastech výzkumu, včetně přírodních věd, materiálových věd, chemické syntézy, chromatografie, analytiky a mnoha dalších..

Obraťte se na technický servis.